By
AmyT on
March 14, 2012
{Editor’s note: This is the first of a two-part interview with ADA CEO Larry Hausner}
We grassroots patient advocates are typically pretty skeptical of the ADA: Aren’t they tied too closely to industry? Who knows what their real agenda is…? My interest was piqued when we at the ‘Mine received the organization’s statement about a new four-year strategic plan, for our year-end preview of the 2012 plans of the country’s top advocacy groups. The ADA…
Read more »
By
AmyT on
December 2, 2011
Yesterday marks “a milestone” in the development of new technology to help automate the care and treatment of type 1 diabetes, according to JDRF!
The U.S. Food and Drug Administration unveiled its eagerly awaited Draft Guidance document for research and development of the Artificial Pancreas system, and initial reaction from JDRF — in a press conference held yesterday afternoon — was a mix of jubilation and a more measured response that they remain “guardedly optimistic” about the details…
Read more »
Although I was diagnosed at age 8, I spent most of my childhood pretty much oblivious to diabetes advocacy. My family raised money for the annual Walk to Cure Diabetes, but that was it. Only in high school did I become more aware of the devastating impact that diabetes has on people. I applied to be a JDRF Children’s Congress delegate at age 15, and in June 2001, my mother and I traveled to Washington,…
Read more »
